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According to current models, once the cell has
reached terminal differentiation, the enhancer reper-
toire is completely established and maintained by
cooperatively acting lineage-specific transcription
factors (TFs). TFs activated by extracellular stimuli
operate within this predetermined repertoire, landing
close to where master regulators are constitutively
bound. Here, we describe latent enhancers, defined
as regions of the genome that in terminally differenti-
ated cells are unbound by TFs and lack the histone
marks characteristic of enhancers but acquire these
features in response to stimulation. Macrophage
stimulation caused sequential binding of stimulus-
activated and lineage-determining TFs to these
regions, enabling deposition of enhancer marks.
Once unveiled, many of these enhancers did not
return to a latent state when stimulation ceased;
instead, they persisted and mediated a faster and
stronger response upon restimulation. We suggest
that stimulus-specific expansion of the cis-regula-
tory repertoire provides an epigenomic memory of
the exposure to environmental agents.
INTRODUCTION
Mammals contain about 200 specialized cell types whose
distinct transcriptional outputs reflect the selection during devel-
opment of unique combinations of coding and regulatory ele-
ments. Indeed, the repertoire of cis-regulatory elements active
in each distinct lineage, as identified by chromatin marks or
occupancy by transcriptional regulators (Barski et al., 2007;
Heintzman et al., 2007; Wang et al., 2008), is only a small fraction
of all possible genomic regulatory elements, with minimal over-
lap between different cell types (Ernst et al., 2011; Heintzman
et al., 2009; Visel et al., 2009).
Cell-type-specific usage of the cis-regulatory information
reflects the combinatorial activity of sequence-specific tran-
scription factors (TFs) involved in lineage determination and
maintenance of cell identity (Natoli, 2010). Enhancers active in
a given tissue are typically co-occupied by multiple TFs enforc-ing cell-type-specific gene expression programs (Chen et al.,
2008; He et al., 2011; Junion et al., 2012; Siersbæk et al.,
2011; Song et al., 2011; Tijssen et al., 2011). Shaping this
genomic cis-regulatory landscape entails multiple TF activities,
including recruitment of chromatin modifiers, nucleosome re-
modelers, and histone chaperons (Hu et al., 2011; Ram et al.,
2011), eventually resulting in the demarcation of short DNA
stretches that contain accessible TF binding sites (TFBS) brack-
eted by positioned nucleosomes (He et al., 2010; Schones et al.,
2008). Enhancers are marked by monomethylated K4 on the
histone H3 N-terminal tail (H3K4me1) (Heintzman et al., 2007,
2009) and have been classified into poised and active enhancers
based on the absence or presence of histone acetylation, re-
spectively (Creyghton et al., 2010; Rada-Iglesias et al., 2011).
Each cell-type-specific enhancer repertoire provides a unique
cis-regulatory context in which TFs activated by environmental
stimuli operate to modify gene expression. For instance, STAT1
was recruited to preexisting H3K4me1-marked enhancers in
HeLa cells within minutes after interferon gamma (IFNg) stimula-
tion (Heintzmanet al., 2009). Inmammary epithelial cells estrogen
receptor alpha (ERa) was recruited to accessible chromatin sites
established by the forkhead TF FoxA1 (Hurtado et al., 2011).
FoxA1 was also found to organize the enhancer repertoire of
prostate cancer cells, thus directing androgen receptor (AR)
recruitment to predefined genomic sites (Wang et al., 2011).
Transforming growth factor beta (TGFb) stimulation of different
cell types resulted in the recruitment of Smad2/3 to distinct
sets of regulatory elements determined by cell-type-specific
TFs (Mullen et al., 2011). Finally, recruitment of stimulus-induced
TFs such as NF-kB and Lxr in activated macrophages occurs at
cell-type-specific enhancers controlled by the master regulator
Pu.1 (Ghisletti et al., 2010; Heinz et al., 2010; Natoli et al., 2011).
So far, the prevailing concepts are that the enhancer repertoire
represents a predetermined landscape generated and enforced
by the same TFs that control cell identity, and that all transcrip-
tional regulatory events in the differentiated cell occur within this
landscape. This model implies that external stimuli that activate
a transient response cannot change the repertoire of genomic
regulatory elements but solely act on the one that is already
available. Clearly, this represents a homeostatic mechanism
that guarantees robustness in maintenance of cell identity in
spite of a changing environment.
Nevertheless, the behavior of some cell types can be persis-
tently affected by transient stimuli to the point that the resultingCell 152, 157–171, January 17, 2013 ª2013 Elsevier Inc. 157
Figure 1. Latent Enhancers Unveiled by LPS Stimulation of Macrophages
(A) Classification of macrophage enhancers based on their response to LPS stimulation. Numbers refer to the 24 hr time point.
(B) A representative genomic region showing latent enhancers induced by LPS stimulation.
(C) Heatmap showing the dynamic behavior of histone marks and Pu.1 at latent enhancers induced by a 4 hr or 24 hr LPS treatment.
(legend continued on next page)
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cell, while retaining its identity, acquires new functional proper-
ties and a corresponding transcriptional output, which together
can define a new cellular subtype. This phenomenon, often
indicated as plasticity, is well known in cells of the myeloid
lineage such as macrophages, neutrophils, and dendritic cells,
whose exposure to different stimuli results in subtypes with
specific properties (Biswas and Mantovani, 2010; Fridlender
et al., 2009; Lawrence and Natoli, 2011).
In this study, we addressed the hypothesis that stimulation-
induced plastic changes in cell behavior may be associated
with a partial reprogramming of the available cis-regulatory infor-
mation. To this aim we carried out a systematic analysis of the
impact of stimuli affecting macrophage properties and transcrip-
tional outputs (Mosser and Edwards, 2008) on their enhancer
repertoire. We classifiedmacrophage enhancers in several cate-
gories based on their response to distinct stimuli, thus deter-
mining general principles regulating the dynamic usage of the
genomic regulatory information. As expected, a large number
of pre-existing, poised enhancers were specifically activated in
response to distinct stimuli, and in a reciprocal fashion many
active elements were repressed upon stimulation. Each stimulus
also allowed the surfacing of a distinct subset of latent
enhancers, namely genomic regulatory elements that were
unbound by TFs and unmarked in unstimulated cells. These
enhancers recruited the macrophage master regulator Pu.1
only in response to stimulation and conditionally to the recruit-
ment of stimulus-activated TFs such as STAT1 and STAT6,
thus indicating a mechanisms of enhancer induction and ac-
tivity that is radically different from that of classical enhancers
established during differentiation by cooperative binding of
lineage-determining TFs. Washout of the stimulus resulted in
the rapid loss of acetylation and Pu.1 occupancy, whereas
residual H3K4me1 was sustained and associated with a faster
and stronger induction upon restimulation, thus providing an
epigenomic memory of the initial stimulation.
RESULTS
Latent Enhancers Are a Distinct Class of cis-Regulatory
Elements
TFs activated by macrophage stimulation with a canonical
inflammatory agent (lipopolysaccharide [LPS]), such as NF-kB
and IRFs, land at regulatory elements predefined by Pu.1 and
constitutively marked by H3K4me1 (Barish et al., 2010; Escou-
bet-Lozach et al., 2011; Ghisletti et al., 2010; Heinz et al.,
2010). Although this is the most common occurrence, these
data do not rule out the possibility that stimulation may also
modify the pre-existing regulatory landscape. We therefore
generated a panel of ChIP-seq data sets exploring the regulatory
repertoire of mouse bone marrow-derived macrophages stimu-
lated with LPS for 4 and 24 hr.
Data obtained with each antibody at different time points
showed higher correlation (e.g., R2 = 0.936 considering(D) Proximity of latent enhancers to LPS-inducible genes.
(E) GO categories of genes assigned to LPS-activated latent enhancers (as infer
(F) In vivo induction of two latent enhancers in LPS-induced peritoneal macroph
See also Figure S1 and Tables S1, S2, and S3.H3K4me1 in untreated and 4 hr LPS-treated cells) compared
to data obtained with a different antibody (e.g., R2  0.1 when
comparing H3K4me1 with H3K4me3 in untreated cells), indi-
cating high reproducibility. Overall, response to stimulation
was highly dynamic, allowing the classification of 65,000
regulatory elements in multiple classes (Figure 1A; Table S1
available online). Constitutive enhancers were associated with
both H3K4me1 and H3K27Ac in unstimulated cells. Of the
14,902 constitutive enhancers we detected, 2,261 showed
increased acetylation after a 24 hr LPS treatment (constitutive-
activated enhancers; Table S1). Poised enhancers showed basal
H3K4me1 without H3K27Ac. Most of them (37,629) were unaf-
fected by LPS stimulation at either time point, whereas a com-
paratively small subset (poised-activated enhancers) acquired
H3K27Ac (3,904 at 4 hr and 3,045 at 24 hr). Poised enhancers
unaffected by stimulation likely represent a heterogeneous set
that may also include constitutively repressed elements (Bonn
et al., 2012). Repressed enhancers (11,150 at 4 hr and 9,004
at 24 hr) displayed constitutive H3K27Ac that was either lost
or greatly reduced upon stimulation (in most of these cases
H3K4me1 was unaffected).
The most unexpected behavior was observed at genomic
regions that were unmarked in untreated macrophages and
acquired enhancer features upon LPS stimulation (Figures 1A–
1C; Table S1). We named these putative regulatory elements,
whose dynamic behavior differed from all previously identified
enhancer classes, latent enhancers to highlight the notion that
they are inactive, unbound, and unmarked in the basal state,
being selectively unveiled by stimulation.
Latent enhancers were identified on the basis of two restric-
tive criteria: (1) the lack of H3K4me1, H3K27Ac, and Pu.1 in un-
stimulated cells even when using relaxed statistical thresholds
(see Extended Experimental Procedures); and (2) the presence
of an LPS-induced H3K4me1 peak using a restrictive threshold
(p < 1010 using MACS). Although the induction of H3K27Ac
was not included among the criteria (because acetylation is
not invariably detected at enhancers), in the overwhelming
majority of cases acquisition of H3K4me1 was accompanied
by the appearance of H3K27Ac (Figures 1B and 1C). Fre-
quently, histone acetylation was only transiently increased at
4 hr and then returned to low-to-undetectable levels at 24 hr
(see Figure 1B and the upper area of Figure 1C). At the same
regions where this behavior was detected, in most cases
H3K4me1 remained steadily elevated at 24 hr, indicating an
uncoupling of these two marks at later time points. Transient
H3K4me1 was detected at a comparatively small number of
regions.
Using these criteria, 514 latent enhancers were identified at
4 hr and 1,002 at 24 hr post-LPS stimulation (Table S1). Although
LPS-induced latent enhancers represented a relatively small
fraction of the total enhancer repertoire, they made up 15.8%
of the total pool of enhancers activated by LPS in this system
(1,002/6,308).red from a GREAT analysis) (McLean et al., 2010).
ages. Data are expressed as mean ± SEM.
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We also considered additional features known to be asso-
ciated with enhancers, including increased accessibility of
genomic DNA (Gross and Garrard, 1988), binding of histone
acetyltransferases (HATs) (Heintzman et al., 2007), RNA Pol II,
and noncoding transcription (De Santa et al., 2010; Kim et al.,
2010). None of these marks could be used to identify latent
enhancers in untreated macrophages, as virtually no overlap
could be observed between latent enhancers and regions of
basal genomic DNA accessibility (measured by formaldehyde-
assisted isolation of regulatory elements [FAIRE]; 0.79%) (Giresi
et al., 2007), basal p300 (0.37%) (Ghisletti et al., 2010), RNA Pol II
(0.6%), and noncoding chromatin-associated transcripts (Bhatt
et al., 2012) (Figures S1A and S1B). Although we cannot rule
out the existence of additional, as yet unknown features that
may be associated with latent enhancers prior to stimulation,
these data support the definition of latent enhancers as a class
of regulatory elements that cannot be identified in unstimulated
cells using currently available markers and appear in terminally
differentiated cells conditionally to stimulation.
To evaluate the contribution of latent enhancers to the
LPS-induced gene expression program, we generated ChIP-
seq data sets for RNA Pol II in naive and LPS-stimulated
macrophages and analyzed the genomic distribution of latent
enhancers relative to the transcription start site (TSS) of LPS-
regulated genes. We assigned enhancers from different classes
to the nearest gene induced in response to stimulation (Table
S2). Proximity to LPS-responsive genes was different among
enhancer classes, latent enhancers being generally associated
with LPS-inducible genes (p < 13 1015 in a chi-square test, Fig-
ure 1D). Latent enhancers were located closer to the assigned
genes than both poised-activated and constitutive enhancers
(p = 1.5 3 108 and p = 2.8 3 1025) (Figure S1C). We then
scored latent enhancers for the associated functional categories
of the nearby genes using an independent approach (McLean
et al., 2010). Strong functional enrichments were observed (Fig-
ure 1E), suggesting that latent enhancers contribute to the
activation of specific components of the LPS response.
Genes are activated by LPS with very different kinetics.
Therefore, we analyzed the association of latent enhancers
with genes activated at different times after LPS stimulation.
Considering the seven recently reported kinetic classes of
LPS-induced genes (Bhatt et al., 2012), we found that the
classes of genes with faster activation kinetics were underrep-
resented among the inducible genes associated with latent
enhancers (p = 8.9 3 106 in a chi-squared test). Therefore,
latent enhancers may be mainly dedicated to the activation of
slowly induced genes. Conversely, no obvious bias was
observed for genes subjected or not to LPS tolerance (i.e., genes
resistant to a second LPS stimulation) (Foster et al., 2007).
Additional features that support the functionality of latent
enhancers include: (1) their sequence conservation (Fig-
ure S1D), (2) the enrichment for specific TFBS (Table S3), and
(3) their ability to promote expression of a reporter gene
driven by a minimal promoter (14/24, 58.8% of tested en-
hancers) (Figure S1E). Finally, latent enhancer unveiling could
also be observed in vivo in LPS-elicited peritoneal macrophages
(Figure 1F), thus further supporting their potential biological
relevance.160 Cell 152, 157–171, January 17, 2013 ª2013 Elsevier Inc.A Complex Repertoire of Latent Enhancers Unveiled by
Distinct Stimuli
These data suggest that the emergence of latent enhancers may
represent a general feature of the response of differentiated cells
to external stimuli. Macrophages are equipped with a plethora of
receptors allowing them to sense, and react to, a broad panel of
agonists (Medzhitov and Horng, 2009). Thus, we treated macro-
phages with different stimuli with varying degrees of functional
overlap, and analyzed alterations of the enhancer repertoire
and transcriptional outputs. Stimuli included (1) two Toll-like
receptor (TLR) agonists specific for TLR2 (macrophage-acti-
vating lipopeptide-2 [MALP-2]) and TLR9 (unmethylated CpG-
containing oligonucleotide) (Kawai and Akira, 2011); these
stimuli differ from LPS (acting on TLR4) mainly because of their
inability to induce IRF3-dependent transcription of the interferon
beta (IFNb) gene, which generates a secondary wave of induc-
ible transcription in this system (Doyle et al., 2002); (2) interleukin
4 (IL-4) and IFNg, two cytokines that induce macrophage polar-
ization toward an anti-inflammatory (M2) or pro-inflammatory
(M1) phenotype, respectively (Mosser and Edwards, 2008); (3)
tumor necrosis factor-alpha (TNFa) and interleukin 1-beta (IL-
1b), two inflammatory cytokines; and (4) the immunoregulatory
cytokine TGFb.
Each stimulus induced histone acetylation at a discrete sub-
set of poised enhancers ranging from 2,142 (TGFb) to 3,371
(MALP-2) elements (Figure 2A; Table S4). An even higher number
of constitutively acetylated enhancers that ranged between
4,174 (IL-1b) and 8,046 (IFNg), displayed loss or reduction of
acetylation upon stimulation. All stimuli were also able to unveil
distinct and comparatively small sets of latent enhancers
(Figures 2A and 2B; Table S4), indicating that the unveiling of
selected regulatory elements is a hallmark of the cellular reaction
to changing environments. As seen with LPS, induction of
H3K4me1 usually occurred concurrently with histone acetylation
and often with recruitment of Pu.1 (Table S4).
The data sets described above allowed us to identify 2,140
latent enhancers that emerged in response to at least one
stimulus. Becausewe used a limited panel of agonists, represen-
tative of just a fraction of the environmental complexity macro-
phages can be exposed to, and given that for all stimuli except
LPS just a single time point was analyzed, it appears evident
that the hidden repertoire of regulatory elements that may
emerge in response to stimulation is much larger.
We next interrogated our ChIP-seq data sets to determine to
what extent stimuli induced shared rather than unique sets of
latent enhancers. The overlap between different stimuli closely
reflected their functional similarity. TLR agonists activated
largely overlapping groups of latent enhancers, with each stim-
ulus also retaining the capacity to unveil distinct and specific
regulatory regions (Figure 2B). A significant fraction of the latent
enhancers common to TLR agonists was also activated by proin-
flammatory cytokines (TNFa and IL-1b). The immunoregulatory
cytokine TGFb, apart from inducing a unique repertoire of latent
enhancers, also activated enhancers responsive to inflammatory
agents, suggesting a possible integration of multiple signals at
these regions. IFNg and IL-4 were able to induce two large
sets of unique and nonoverlapping latent enhancers (Figures
2B and S2), consistent with their opposing functions as
Figure 2. The Complex Repertoire of Latent Enhancers Induced by Distinct Macrophage Activators
(A) Genomic snapshot showing poised-activated and latent enhancers induced in response to a panel of macrophage activators.
(B) Circos visualization of latent enhancers induced by multiple stimuli.
(C) Correlation matrix of the number of reads (log2) for latent enhancers activated by each stimulus. Pearson correlation values are shown by color and intensity of
shading. Variables were ordered by PCA (principal component analysis).
(D) Heat-map showing the distance between each latent enhancer (represented by an individual line) and the closest gene regulated by the same stimulus.
See also Figure S2 and Tables S4, S5, and S6.M1 and M2 macrophage polarizers, respectively. Overall, CpG
DNA, MALP-2, and TNFa were highly correlated, whereas LPS
and IFNg were anticorrelated to IL-4 (Figure 2C). Latent
enhancers induced by a given stimulus were frequently at a short
distance from a gene regulated by the same stimulus (Figure 2D)
and, as shown above for LPS, they were significantly closer tocandidate target genes than poised-activated (p = 2.2 3 1016)
or constitutive (p = 1.04 3 1013) enhancers. Finally, different
functional categories were enriched in sets induced by different
stimuli (Table S5).
To gain insight into the process of unveiling of latent
enhancers, we identified TFBS overrepresented in the setsCell 152, 157–171, January 17, 2013 ª2013 Elsevier Inc. 161
Figure 3. Sequence-Specific TFs Recruitment to Latent Enhancers
(A) TFBS overrepresented in latent enhancers unveiled by different stimuli. For all agonists, PWMs identified by de novo motif discovery and relative E values
(obtained using MEME) are shown at the top line. Below each motif the two top-ranking Jaspar matrices are shown.
(B and C) ChIP-seq analysis of JunB, Stat6, and Stat1 recruitment to latent enhancers induced in response to LPS, IL-4, and IFNg, respectively. Heatmaps show
the normalized number of reads in the genomic area of each latent enhancer before and after stimulation. Regions are sorted based on tag density after
stimulation. The green flags on the right highlight the presence of a statistically significant peak at 4 hr (MACS, p% 1 3 105). The PWMs obtained by de novo
motif discovery on the peaks of each TF at the respective latent enhancer set are shown in (C).
(D) A representative snapshot showing JunB recruitment to an LPS-induced latent enhancer.
See also Figure S3.induced by different stimuli (Figure 3A; Table S6). Latent
enhancers induced by TLR agonists were mainly enriched in
AP-1 sites, whichmay relate to the reported ability of AP-1 family
TFs to promote chromatin opening (Biddie et al., 2011). Consis-
tently, the AP-1 protein JunB was inducibly recruited to the
majority (79.6%) of LPS-dependent latent enhancers (Figure 3B).
De novo motif discovery on sequences bound by JunB in latent
enhancers retrieved a canonical AP-1 matrix (Figure 3C). A
representative snapshot is shown in Figure 3D. Enhancers
induced by TGFb were associated with a SMAD-type binding
site and recruited Smad3 (Figure S3), whereas different types162 Cell 152, 157–171, January 17, 2013 ª2013 Elsevier Inc.of STAT sites were overrepresented in the IL-4 and IFNg sets
(Figure 3A). IL-4-induced latent enhancers were associated
with an inverted repeat 50-TTCNNNNGAA-30 that matches the
STAT6 binding motif identified in ChIP-seq experiments (Elo
et al., 2010). Consistently, analysis of STAT6 genomic distribu-
tion in IL-4-treated (4 hr) macrophages revealed an extensive
association with IL-4-induced latent enhancers (Figure 3B), and
de novo motif discovery on these sequences retrieved the
same inverted repeat (Figure 3C). IFNg-induced latent enhancers
were associated with an IRF-type STAT site. Homodimeric
STAT1 binds canonical STAT binding sites (50-TTCCNGGAA-30)
(Robertson et al., 2007); however, within a trimeric complex with
STAT2 and IRF9, which can be activated by IFNg (Matsumoto
et al., 1999) binding occurs at IRF-type binding sites formed
by direct repeats of 50-GAAA-30 units (Taniguchi et al., 2001).
A Stat1 ChIP-seq confirmed its broad association with latent
enhancers activated by IFNg (Figure 3B), and the underlying
binding site identified by de novo motif discovery was indeed
an IRF-type site (Figure 3C), thus confirming that the STAT1 iso-
form involved in the formation of latent enhancers in response to
IFNg is probably a complex with IRFs.
In addition, binding sites similar but not perfectly identical to
those for themacrophagemaster regulator Pu.1 were overrepre-
sented in all latent enhancer sets.
Mechanistic Aspects of Latent Enhancers
We focused on IL-4 and IFNg because they both operate through
an experimentally tractable two-step pathway that includes
a receptor-associated JAK family tyrosine kinase and a STAT
family TF whose phosphorylation triggers nuclear translocation
and transcriptional activation (Darnell et al., 1994).
We first analyzed the kinetics of increase of H3K4me1,
H3K27Ac, and Pu.1 at representative enhancers. With both
IL-4 and IFNg, signals increased slowly and in a progressive
manner and their kinetics were similar (Figures 4A and 4B).
Consistently, FAIRE indicated that basal accessibility of latent
enhancers was low and identical in macrophages and in
Hepa1-6 hepatocytes, an unrelated cell line used for comparison
(Figures 4A and 4B). In response to stimulation, FAIRE signals
increased in a progressive fashion that was indicative of an
ongoing nucleosomal reorganization, eventually leading to an
increased central region of high accessibility bracketed on
both sides by modified nucleosomes (Figure 4C).
STAT6 and STAT1 recruitment to latent enhancers showed
peculiar kinetic properties (Figures 4A and S4A). The slow
increase in STAT1 and STAT6 occupancy, which resembled
the slow changes in accessibility and the deposition of histone
modifications, was dissociated from bulk changes in TF phos-
phorylation, as this was already maximal at 10 min poststimula-
tion (Figure 4D). However, consistent with its rapid activation and
nuclear translocation, STAT6 was recruited with fast kinetics to
other regulatory regions, such as the promoter of the IL-4-induc-
ible Ccl12 gene (Figure S4B). Therefore, although STAT6 is fully
competent for DNA binding at early time points, it could not be
quickly recruited to latent enhancers.
To determine the kinetic properties of latent enhancers at
genome scale, we generated ChIP-seq data sets at multiple
time points after IL-4 (Figure 4E) or IFNg treatment (Figure S4D).
Genomic data confirmed that the activation of latent enhancers
is a relatively slow process, particularly if compared to the
kinetics of TF activation (Figure 4D) and to the kinetics of TF
recruitment to poised enhancers, which was often maximal at
15 min poststimulation (enhancer marked by asterisks in Fig-
ure 4E). Moreover, kinetics of STAT TF recruitment often pre-
ceded the deposition of H3K4me1 and in some cases also
Pu.1 recruitment (Figures 4E and S4D).
Mechanistically, the kinetic discrepancy between STAT1 or
STAT6 activation and their recruitment to latent enhancers,
together with the slow increase in accessibility and histonemark deposition described above, indicate that the STAT TF
binding sites in latent enhancers are not immediately available
for binding. Clearly, the time lag between stimulation and
maximal occupancy must be interpreted in the context of a pop-
ulation analysis, and be taken as evidence of a progressively
increasing fraction of cells in which STAT binding sites in latent
enhancers are exposed. TFBS at latent enhancers were not
covered by positioned nucleosomes in unstimulated macro-
phages, as indicated by homogeneous H3 signals (Figure S4C).
Upon stimulation, nucleosomal occupancy was increased on
both sides of a centrally located, H3-depleted area of the
enhancer (Figures S4C and 4C), likely because of the barrier
effect exerted by newly recruited TFs (Jiang and Pugh, 2009; Se-
gal and Widom, 2009; Valouev et al., 2011). Lack of a well-posi-
tioned nucleosome in the basal state implies that nucleosomes
at latent enhancers are allowed to undergo lateral movements
leading to stochastic fluctuations in their positions. In turn,
such movements may create windows of opportunity for TF
binding. Once the STAT TF are bound they may recruit Pu.1
and together stabilize the open and accessible state by recruit-
ing chromatin-remodelers (Cui et al., 2004; Huang et al., 2002;
Liu et al., 2002), as demonstrated at the promoters of inflamma-
tory genes (Ramirez-Carrozzi et al., 2009).
To determine the role of STAT TFs in latent enhancer unveiling,
we first used a Jak kinase inhibitor (Jak-i) that blocked STAT TF
phosphorylation without affecting other pathways activated by
these cytokine receptors (such as the ERK/MAPK pathway) (Fig-
ure 5A). Jak-i blocked the induction of H3K4me1 and H3K27Ac
in response to IL-4 and IFNg (Figures 5B and 5C). Pu.1 recruit-
ment was also entirely dependent on Jak-Stat signaling.
We next analyzed at genome scale the impact of Stat6 and
Stat1 gene loss on IL-4 and IFNg induction of latent enhancers.
De novo histone mark deposition and Pu.1 recruitment to latent
enhancers were entirely dependent on STAT TFs activation, as
virtually no latent enhancer could be detected in their absence
(Figures 5D and 5E). A representative snapshot is shown in
Figure 5F.
We noticed that new Pu.1 peaks were in some cases located
within inducible genes (Figure S5A) and therefore we considered
the possibility that in those specific cases RNA-Pol II-dependent
nucleosome displacement and chromatin opening may increase
accessibility of latent sites. Blockade of RNA Pol II elongation
by the Cdk9 inhibitor DRB blocked Pu.1 recruitment to one
such enhancer locatedwithin theNos2 gene (Figure S5B). There-
fore, in some cases RNA Pol II may play an active role in
promoting the surfacing of latent enhancers contained within
partially inaccessible chromatin. Conversely, the protein syn-
thesis inhibitor puromycin only marginally impaired H3K4me1
induction (Figure S5C).
A most intriguing observation was the lack of constitutive Pu.1
binding at latent enhancers in spite of the presence of Pu.1 sites.
Indeed, Pu.1 is considered a pioneer factor able to invade nucle-
osomal chromatin and to promote both the formation of nucleo-
some-free regions and the deposition of H3K4me1 at adjacent
nucleosomes (Ghisletti et al., 2010; Heinz et al., 2010). Lack of
basal Pu.1 binding at latent enhancers may be explained by
different mechanisms, including: (1) an actively enforced repres-
sive chromatin state that renders the underlying binding sitesCell 152, 157–171, January 17, 2013 ª2013 Elsevier Inc. 163
Figure 4. Kinetic Analysis of Latent Enhancers
(A) Kinetics of H3K4me1 and H3K27Ac deposition, Pu.1 and Stat1 (or Stat6) recruitment, DNA accessibility (FAIRE) at representative IL-4- (left) and IFNg-induced
(right) latent enhancers. Hepa1-6, mouse hepatocyte cell line. Data are expressed as mean ± SEM.
(legend continued on next page)
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unavailable for binding, and (2) the presence of low affinity
binding sites that cannot support recruitment of Pu.1 without
cooperation provided by a partner TF activated by stimulation.
An additional possibility is that Pu.1’s pioneering function may
be dependent on cooperative binding or synergy with constitu-
tively expressed TFs that bind adjacent sites, which may be
absent at the latent enhancers. Regarding the first mechanism,
we investigated by ChIP the presence of negatively acting his-
tone marks. Levels of H3K27me3, H3K27me2, and H3K9me3
were undetectable or very low at all latent enhancers tested
(Figures 6A and S6A), indicating that these marks were not
involved in maintenance of basal repression.
Consistent with the second mechanism, Pu.1 binding sites
within latent enhancers displayed lower affinities as compared
to those in constitutively bound enhancers. First, using in vitro
determined binding affinities (Wei et al., 2010), we computed
the Pu.1 binding affinities for the consensus sites found in the
different classes of enhancers. The sites in latent enhancers
showed much lower affinities for Pu.1 relative to constitutive
enhancers (Wilcoxon test p value 7.063 1054) and poised-acti-
vated enhancers (p value 1.01 3 1065). Instead poised-
activated and constitutive enhancers showed similar binding
affinities (p value 0.02) (Figure 6B). Second, we computed the
distributions of best matches for the Pu.1 position weight matrix
(PWM) derived from ChIP-seq data (Heinz et al., 2010) for each
class of enhancers. The cumulative distribution of PWM scores
for constitutive, steady and poised enhancers showed nearly
overlapping distribution frequencies (Wilcoxon test p value
0.017) (Figure 6C), whereas latent enhancers showed a sig-
nificant divergence in sequence composition (p values 6.931 3
10117 and 1.113 3 1095 relative to poised and constitutive
enhancers, respectively) (Figure 6C). Overall, these data indicate
that the composition of Pu.1 binding sites in latent enhancers
diverges from canonical high affinity sites enough to prevent
Pu.1 binding in basal conditions; however, these low affinity sites
allow Pu.1 recruitment in the presence of cooperating stimulus-
activated TFs.
Latent Enhancers and Short-Term Transcriptional
Memory
We therefore investigated whether newly activated latent en-
hancers could be maintained in the absence of a sustained
stimulation. Cells were treated with IL-4 or IFNg for either 4 hr
or 24 hr, washed and incubated in fresh medium for additional
48 hr before harvesting (Figure 6D). Complete loss of STAT1 or
STAT6 phosphorylation after washout confirmed efficient signal
termination (Figure 6D). Histone acetylation, accessibility and
Pu.1 occupancy all returned to prestimulation levels upon cyto-
kine removal (Figure 6E). STAT1 and STAT6 binding to latent(B) Data from multiple latent enhancers activated by either IL-4 or IFNg are show
(C) A representative IL-4-induced latent enhancer was analyzed using multiple
summit of the inducible Pu.1 peak. Data are expressed as mean ± SEM.
(D) Western blots with phospho-specific STAT6 and STAT1 antibodies showing
(E) ChIP-seq analysis of IL-4-dependent latent enhancer induction kinetics. A re
indicate a poised enhancer where Stat6 recruitment was already maximal at 150
progressive. The box plots indicate relative tag counts at all mapped IL-4 latent
See also Figure S4.enhancers were also lost after washout (Figure 6E). These obser-
vations indicate that following the initial recruitment, sustained
Pu.1 occupancy required the constant presence of cytokine-
activated STAT1 or STAT6, thus suggesting a strong functional
cooperativity. As a consequence of the removal of STAT1/Pu.1
or STAT6/Pu.1 from DNA, histone acetylation and accessibility
of latent enhancers were completely lost. Instead, H3K4me1
persisted for days after the washout (Figures 6E and S6B), indi-
cating an autonomous sustainment of this mark. We generated
H3K4me1 ChIP-seq data sets to determine the fraction of latent
enhancers that were retained after extensive washout. We found
that of the 1,002 newly formed H3K4me1 peaks that were
detected at 24 hr of IFNg treatment and persisted after 72 hr of
continuous stimulation, 307 (30.6%) were also detected after
a 48 hr washout (Figure 6F). These data show that a large fraction
of latent enhancers remains stably marked in the absence
of continuous stimulation. Therefore, by uncovering a specific
and previously hidden repertoire of enhancers, each stimulus
generates an epigenomic signature of its exposure.
Residual marking by H3K4me1 was indicative of a poised
state of these enhancers after cytokine washout. When primed
cells were restimulated with the same agonist used in primary
stimulation, faster acetylation kineticswere observed (Figure 7A).
Moreover, final levels of acetylation were consistently higher
than those achieved in response to primary stimulation. These
data are consistent with the notion that the H3K4me1 mark
primes enhancers for recruitment of HATs (Jeong et al., 2011).
Finally, genes adjacent to latent enhancers were induced faster,
and often to higher levels in response to secondary stimulation
(Figure 7B). These enhancing effects were not due to a stronger
induction of the Jak/Stat signal transduction pathway in restimu-
lated cells, because levels of phospho-STATs were comparable
to those found in unprimed macrophages (Figure 7C).
As shown above (Figure 2), stimuli differed in their ability to
cause the emergence of latent enhancers. However, the pres-
ence of complex combinations of TFBS may in principle enable
cross-reactivation once the latent enhancer has surfaced. To
test this hypothesis, we primed macrophages with IL-4 and after
cytokine washout, we restimulated them with a panel of different
agonists. In some cases, latent enhancers were promiscuously
induced by multiple stimuli and retained increased responsive-
ness to the same agonists upon restimulation (Figure 7D, left).
At other enhancers induced selectively by IL-4, responsiveness
to secondary stimulation was exquisitely restricted to IL-4 (Fig-
ure 7D, middle). Finally, in other cases, reactivation of a surfaced
IL-4-induced latent enhancerwashighly promiscuous (Figure 7D,
right) indicating that although the primary exposure of these
elements was highly selective, the very same enhancers could
be subsequently acted upon by TFs activated bymultiple stimuli.n. Each line represents a different enhancer.
primers spanning a 3 kb region. The central position (0) corresponds to the
their activation kinetics.
presentative genomic region is shown on the left. The asterisks (bottom right)
, as opposed to the latent enhancer shown on its left, where recruitment was
enhancers.
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Figure 5. STAT TFs Requirement for the Unveiling of Latent Enhancers in Response to IL-4 and IFNg Stimulation
(A) Inhibition of STAT tyrosine phosphorylation but not MAPK ERK phosphorylation by a selective Jak kinase inhibitor (Jak-i).
(B and C) Inhibition of histone marks deposition and Pu.1 recruitment by Jak-i at individual enhancers (B) or at a panel of IL-4- or IFNg-induced latent enhancers
(C). Data in (B) are expressed as mean ± SEM.
(legend continued on next page)
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DISCUSSION
In this study, we report a distinct class of transcriptional en-
hancers whose main distinguishing features are: (1) lack of basal
marking and TF binding in fully differentiated cells, (2) acquisition
of enhancer marks and accessibility upon stimulation, (3) depen-
dence on both stimulus-activated TFs and lineage determining
TFs, (4) selective retention of H3K4me1 upon signal termination,
and (5) faster and/or augmented response upon secondary stim-
ulation. Although the repertoire of available cis-regulatory ele-
ments in a given cell type appears to be a specific property of
its differentiated state and to be directly controlled by the
enhancer-organizing activity of lineage-determining TFs (Natoli,
2010), the repertoire of surfaced latent enhancers is determined
by the functional cooperation between stimulus-activated TFs
and lineage-restricted TFs, thus integrating cell-type-specific
and stimulus-specific inputs.
We suggest that the unveiling, and the subsequent retention, of
an agonist-specific repertoire of latent enhancers can be consid-
ered an epigenomic footprint (or scar) of the stimuli the cell has
previously been exposed to. The surfacing of latent enhancers
also implies an expansion of the repertoire of accessible regula-
tory elements,which effectively changes thewaycells respond to
a subsequent stimulation. It has been previously reported that in
macrophages that underwent a prolonged exposure to LPS,
although some genes cannot be reactivated upon washout and
secondary LPS stimulation, many others were hyperinduced
(Foster et al., 2007), a phenomenon that may relate to the expan-
sionof the enhancer repertoirewedescribed here. In this context,
it is interesting to note that once unveiled, some latent enhancers
become responsive to stimuli that were unable to induce their
exposure in naive cells. Therefore, not only does the surfacing
of latent enhancers change the way cells respond to repeated
challenges with the same stimulus, but also the way a precondi-
tioned cell will respond to stimuli it never encountered before.
Mechanistically, latent enhancers can be distinguished from
those poised enhancers whose basal inactivity is associated
with both H3K4me1 and H3K27me3 (Rada-Iglesias et al.,
2011). Our data suggest that lack of marking of latent enhancers
in the basal state reflects the fact that these enhancers are
ignored because of a combination of two main factors: nucleo-
some occlusion and a comparatively low affinity for Pu.1, which
would otherwise be able to invade nucleosomal DNA and induce
enhancer formation (Ghisletti et al., 2010; Heinz et al., 2010).
Upon stimulation, Pu.1 can gain access to such sites (and
promote the organization of an active enhancer) because of
the functional cooperation provided by stimulus-activated TFs.
However, the slow kinetics of surfacing of latent enhancers is
not compatible with a simple model of cooperative binding,
because in this case Pu.1 recruitment and enhancer organization
would occur immediately after the nuclear translocation of
inducible TFs such as STAT1 or STAT6. Conversely, the time
lag between activation of the STAT TFs and their recruitment(D–F) STAT6 (D) and STAT1 (E) requirement for IL-4- or IFNg-mediated induction
de novo deposition of histone marks and Pu.1 recruitment at latent enhancers,
signed-rank test). A representative snapshot from Stat6/ macrophages is show
See also Figure S5.(together with Pu.1) to latent enhancers suggests the existence
of an additional regulatory layer that may be due to nucleosomal
interference with DNA binding. Reorganization of the nucleo-
somal spacing at latent enhancers may reflect either an active
process mediated by chromatin remodelers or random fluctua-
tions in the position of nonfixed nucleosomes. In the first case,
TFs such as the STAT TF and AP-1 endowed with the ability to
recruit chromatin-remodeling complexes (Cui et al., 2004; Huang
et al., 2002; Liu et al., 2002; Biddie et al., 2011) would initially
make short contacts with partially occluded binding sites within
latent enhancers, thus promoting (in combination with Pu.1) their
opening via an iterative process involving the repetition of tran-
sient binding events followed by progressively increased site
exposure. The second possibility is that either nucleosome turn-
over or spontaneous lateral movements of nucleosomes that are
not constrained because of the lack of either adjacent barriers or
positioning signals (Valouev et al., 2011) would create windows
of opportunity for TF binding, thus eventually leading to the stabi-
lization of the open state. Upon stimulus termination and release
of the bound TFs, loss of the barrier activity they exerted would
allow spontaneous nucleosome repositioning and loss of acces-
sibility. Nevertheless, H3K4me1 marking will persist and pro-
mote a faster reinduction at restimulation, which may reflect
a direct reading of this mark by HATs (Jeong et al., 2011).
Our experimental system does not allow determining
the potential for transmission of the unveiled repertoire of
latent enhancers across DNA synthesis. Therefore, retention of
the H3K4me1 mark—and the associated functional conse-
quences—after stimulus termination can only be discussed
here in the context of short-term transcriptional memory mech-
anisms. In any case, such short-term epigenomic memory may
have great functional implications in postmitotic cells such as
neurons. Indeed, it will be interesting to determine if brain
memory circuits, in which epigenetic phenomena have been
suggested to play an important role (Levenson and Sweatt,
2005), also involve latent enhancers.
EXPERIMENTAL PROCEDURES
Antibodies, Reagents, Cell Culture Procedures, Cloning,
Transfections, and RNA Analyses
For information on antibodies, reagents, cell culture procedures, cloning,
transfections, and RNA analyses, please refer to the Extended Experimental
Procedures.
Chromatin Immunoprecipitation and Sequencing
ChIP was carried out using either a previously described protocol (Ghisletti
et al., 2010) or a high-throughput protocol (Garber et al., 2012). Briefly,
5–15 3 106 (ChIP-seq for histone marks and Pu.1) or 100 3 106 (ChIP-seq
for other TFs and RNA Pol II) fixed macrophages were lysed with RIPA buffer
and, after chromatin shearing by sonication, incubated overnight at 4C
with protein G Dynabeads (Invitrogen) that were previously coupled with
3–10 mg of antibody. For ChIP-qPCR experiments, 10%–20% of cells indi-
cated above were used, and IP was performed using 1–3 mg of antibody. After
immunoprecipitation, beads were recovered using a 96-well magnet, washed,of latent enhancers. Box plots show the consequence of STAT TF absence on
as measured by ChIP-seq (p values calculated with paired-samples Wilcoxon
n in (F).
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Figure 6. Mechanistic Dissection of Latent Enhancer Formation
(A) Repressive histone marks at representative latent enhancers. The first column on the left is a positive control for each modification. For each modification, the
enhancers were ranked based on decreasing signal intensity. Data are expressed as mean ± SEM.
(B) Analysis of Pu.1 binding sites at latent enhancers as compared to constitutively bound Pu.1 sites (in constitutive and poised-activated enhancers). The Z score
was calculated using Pu.1 affinity data obtained from protein binding microarrays (Wei et al., 2010). The p values shown were obtained using a Wilcoxon test.
(C) Cumulative distribution for PWM scores in latent enhancers and two control groups. The reference PWM used was generated from in vivo binding data (Heinz
et al., 2010). The p values were generated by a Wilcoxon test. Ecdf, empirical cumulative distribution function.
(legend continued on next page)
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Figure 7. A Short-Term Memory Associated with Latent Enhancers
(A) Acetylation kinetics at latent enhancers upon restimulation.
(B) Induction of genes adjacent to latent enhancers upon restimulation.
(C) STAT TF activation upon secondary stimulation.
(D) Selective versus promiscuous activation of latent enhancers by alternative stimuli. Three different representative behaviors are shown. The enhancer on the
left was activated in a promiscuous manner, the one in the middle was selectively activated by IL4 both at primary and secondary stimulation, and the one on the
right was selectively activated by IL4 at primary stimulation but promiscuously at restimulation. ChIP data in (D) refer to a priming of 24 hr and a (re)stimulation of
4 hr. Data in (A), (B), and (D) are expressed as mean ± SEM.and DNA was eluted and decrosslinked overnight at 65C. DNA was then
purified with Solid-phase reversible immobilization (SPRI) beads (Agencourt
AMPure XP, Beckman Coulter) and quantified with PicoGreen (Invitrogen).
For ChIP-QPCR experiments, 0.4 ml of purified DNA was used for amplification
on an ABI 7500 machine. Primers used for ChIP-QPCR are in Table S7. ChIP
DNA was prepared for Solexa GAII or HiSeq2000 sequencing following stan-
dard protocols. Basic data processing was carried out using the Fish-The-
ChIP pipeline (Barozzi et al., 2011). A detailed description of the computational
analyses is provided in the Extended Experimental Procedures.
ACCESSION NUMBERS
Raw data sets have been submitted to the Gene Expression Omnibus data-
base (http://www.ncbi.nlm.nih.gov/geo/) and are available under the acces-
sion GSE38379. R was used to compute statistics and generate plots.(D) Cytokine washout results in signal termination and loss of STAT TF phospho
(E) Pu.1 binding to latent enhancers, acetylation and increased accessibility, bu
mean ± SEM.
(F) Two representative ChIP-seq snapshots showing H3K4me1 behavior at two
See also Figure S6.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and seven tables and can be found with this article online at http://
dx.doi.org/10.1016/j.cell.2012.12.018.
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